P27708 (PYR1_HUMAN) Homo sapiens (Human)

CAD protein UniProtKBInterProSTRINGInteractive Modelling

2225 aa; Sequence (Fasta)

Sequence Features

Add
 252Nucleophile; for GATase activity
 336For GATase activity
 338For GATase activity
 668Magnesium or manganese 1
 682Magnesium or manganese 1
 682Magnesium or manganese 2
 684Magnesium or manganese 2
 1202Magnesium or manganese 3
 1214Magnesium or manganese 3
 1214Magnesium or manganese 4
 1216Magnesium or manganese 4
 1471Zinc 1; via tele nitrogen
 1471Zinc 2; via pros nitrogen
 1473Zinc 1; via tele nitrogen
 1556Zinc 1; via carbamate group
 1556Zinc 3; via carbamate group
 1590Zinc 3; via pros nitrogen
 1613Zinc 2
 1614Zinc 3; via tele nitrogen
 1637Zinc 2
 1686Zinc 1
 33M -> R (in EIEE50; unknown pathological significance; dbSNP:rs751610198) VAR_078289 dbSNP
 177R -> Q (in a colorectal cancer sample; somatic mutation; dbSNP:rs374122292) VAR_035897 dbSNP
 735Y -> C (in a colorectal cancer sample; somatic mutation) VAR_035898
 2024R -> Q (in EIEE50; dbSNP:rs763410987) VAR_073955 dbSNP
 545-600ATP
 1078-1135ATP
 1789-2225Missing (in EIEE50; unknown pathological significance) VAR_078290
 2-137Carbamoyl-phosphate synthase small subunit, N-terminal domain
IPR002474PF00988
 180-355Glutamine amidotransferase
IPR017926PF00117
 514-717Carbamoyl-phosphate synthetase large subunit-like, ATP-binding domain
IPR005479PF02786
 801-877Carbamoyl-phosphate synthetase, large subunit oligomerisation domain
IPR005480PF02787
 1050-1247Carbamoyl-phosphate synthetase large subunit-like, ATP-binding domain
IPR005479PF02786
 1327-1427Methylglyoxal synthase-like domain
IPR011607PF02142
 1464-1524Amidohydrolase-related
IPR006680PF01979
 1924-2065Aspartate/ornithine carbamoyltransferase, carbamoyl-P binding
IPR006132PF02729
 2072-2220Aspartate/ornithine carbamoyltransferase, Asp/Orn-binding domain
IPR006131PF00185

Sequence Alignments

Experimental structures

DescriptionOligo-stateLigandsStructureRange
Aspartate transcarbamoylase domain of human CAD in apo formhomo-3-mer EDO;GOL;5g1o1915-2225
Assess
Aspartate transcarbamoylase domain of human CAD bound to carbamoyl phosphatehomo-3-mer CP;5g1p1915-2225
Assess
Aspartate transcarbamoylase domain of human CAD bound to PALAhomo-3-mer PAL;EDO;5g1n1919-2225
Assess
Crystal structure of the dihydroorotase domain of human CAD with incomplete active site, obtained r…homo-2-mer 10×FMT;GOL;4c6b1460-1839
Assess
Crystal structure of the dihydroorotase domain of human CAD bound to substrate at pH 6.5homo-2-mer DOR;NCD;ZN;FMT;4c6f1460-1823
Assess
Crystal structure of the dihydroorotase domain of human CAD bound to substrate at pH 5.5homo-2-mer DOR;NCD;ZN;FMT;4c6e1460-1823
Assess
Hybrid dihydroorotase domain of human CAD with E. coli flexible loop, bound to dihydroorotatehomo-2-mer FMT;ZN;DOR;6hg31459-1822
Assess
Crystal structure of the dihydroorotase domain of human CAD bound to substrate at pH 7.5homo-2-mer ZN;DOR;NCD;FMT;4c6j1460-1822
Assess
Crystal structure of the dihydroorotase domain of human CAD bound to substrate at pH 7.0homo-2-mer ZN;FMT;DOR;NCD;4c6i1460-1822
Assess
Human dihydroorotase mutant F1563A co-crystallized with carbamoyl aspartate at pH 7.0homo-2-mer ZN;FMT;DOR;6hfh1460-1822
Assess
Crystal structure of the dihydroorotase domain of human CAD bound to substrate at pH 8.0homo-2-mer ZN;NCD;FMT;DOR;4c6k1460-1822
Assess
Crystal structure of the dihydroorotase domain of human CAD bound to the inhibitor fluoroorotate at…homo-2-mer ZN;FMT;FOT;4c6l1460-1822
Assess
Crystal structure of the dihydroorotase domain of human CAD bound to the inhibitor fluoroorotate at…homo-2-mer ZN;FMT;FOT;4c6m1460-1822
Assess
Crystal structure of the dihydroorotase domain of human CAD C1613S mutant bound to substrate at pH …homo-2-mer ORO;ZN;NCD;FMT;4c6q1460-1822
Assess
Crystal structure of the dihydroorotase domain of human CAD E1637T mutant bound to substrate at pH …homo-2-mer ZN;FMT;NCD;4c6n1461-1823
Assess
Human dihydroorotase mutant F1563A co-crystallized with carbamoyl aspartate at pH 7.5homo-2-mer ZN;FMT;DOR;6hfj1460-1821
Assess
Crystal structure of the dihydroorotase domain of human CAD bound to substrate at pH 6.0homo-2-mer DOR;NCD;ZN;FMT;4c6d1460-1821
Assess
Human dihydroorotase mutant F1563Y co-crystallized with carbamoyl aspartate at pH 7.0homo-2-mer ZN;NCD;FMT;6hfr1460-1821
Assess
Human dihydroorotase mutant F1563Y co-crystallized with carbamoyl aspartate at pH 6.5homo-2-mer ZN;NCD;FMT;6hfs1460-1821
Assess
Human dihydroorotase mutant F1563L co-crystallized with carbamoyl aspartate at pH 7.0homo-2-mer ZN;DOR;FMT;6hfl1460-1821
Assess
Human dihydroorotase mutant F1563Y co-crystallized with carbamoyl aspartate at pH 7.5homo-2-mer ZN;NCD;FMT;6hfu1460-1821
Assess
Crystal structure of the dihydroorotase domain of human CAD in apo- form obtained recombinantly fro…homo-2-mer ZN;FMT;4c6c1460-1821
Assess
Human dihydroorotase mutant F1563L co-crystallized with carbamoyl aspartate at pH 6.5homo-2-mer ZN;FMT;DOR;6hfk1460-1821
Assess
Human dihydroorotase mutant F1563A apo structurehomo-2-mer ZN; 10×FMT;6hfi1460-1821
Assess
Human dihydroorotase mutant F1563T apo structurehomo-2-mer ZN; 12×FMT;6hfe1460-1821
Assess
Human dihydroorotase mutant F1563Y apo structurehomo-2-mer ZN;FMT;6hff1460-1821
Assess
Crystal structure of the dihydroorotase domain of human CAD C1613S mutant in apo-form at pH 7.0homo-2-mer ZN;FMT;4c6p1460-1821
Assess
Crystal structure of the dihydroorotase domain of human CAD C1613S mutant in apo-form at pH 6.0homo-2-mer ZN;FMT;4c6o1460-1821
Assess
Crystal structure of the dihydroorotase domain of human CAD in apo- form obtained recombinantly fro…homo-2-mer ZN;FMT;4by31460-1821
Assess
Hybrid dihydroorotase domain of human CAD with E. coli flexible loop, bound to fluoroorotatehomo-2-mer ZN;FOT;FMT;6hg21460-1821
Assess
Human dihydroorotase mutant F1563L apo structurehomo-2-mer ZN;FMT;6hfd1460-1821
Assess
Hybrid dihydroorotase domain of human CAD with E. coli flexible loop in apo statemonomer ZN;FMT;6hg11460-1826
Assess
Crystal structure of the dihydroorotase domain (K1556A) of human CADmonomer ZN;5ynz1460-1822
Assess
Human dihydroorotase mutant F1563T co-crystallized with carbamoyl aspartate at pH 7.5monomer ZN;DOR;FMT;GOL;6hfq1460-1821
Assess
Human dihydroorotase mutant F1563T co-crystallized with carbamoyl aspartate at pH 7.0monomer ZN;DOR;FMT;6hfp1460-1821
Assess
Human dihydroorotase mutant F1563L co-crystallized with carbamoyl aspartate at pH 7.5monomer ZN;FMT;DOR;6hfn1460-1821
Assess

Homology models

Oligo-stateQMEANTemplateRangeSeq id (%)Ligands
homo-2-mer -1.20 5dou.1.A2-1442
52.01MG;K;
Assess